Episode

Neuro-Oncology Nugget: Synthetic Super-Enhancer Gene Therapy for Glioblastoma

Podcast
Neuro-Oncology: The Podcast
Published
Jul 27, 2026
Duration seconds
199
Processing state
not_requested
Canonical source
https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-synthetic-super-enhancer-gene-therapy-for-glioblastoma
Audio
https://traffic.libsyn.com/secure/soc-neuro-onc/nop-147.mp3?dest-id=2339594
JSON
/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-synthetic-super-enhancer-gene-therapy-for-glioblastoma
Markdown
/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-synthetic-super-enhancer-gene-therapy-for-glioblastoma.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-synthetic-super-enhancer-gene-therapy-for-glioblastoma/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-synthetic-super-enhancer-gene-therapy-for-glioblastoma.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Podcast Host and Interviewee: Shahad Abdulsahib, PhD Graduate, UT Health San Antonio Podcast Description: Shahad Abdulsahib discusses a landmark preclinical study evaluating Synthetic Super-Enhancer-based gene therapy for glioblastoma, published in Nature in April 2026, and the rapid translation of these findings into the first-in-human Phase 1/2 ADePT clinical trial with first patient dosing in May 2026.